Padagis Us Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PADAGIS US
PADAGIS US has ninety-two approved drugs.
There is one US patent protecting PADAGIS US drugs.
There are twenty-two patent family members on PADAGIS US drugs in fourteen countries and one hundred and fifty-one supplementary protection certificates in sixteen countries.
Summary for Padagis Us
| International Patents: | 22 |
| US Patents: | 1 |
| Tradenames: | 68 |
| Ingredients: | 64 |
| NDAs: | 92 |
| PTAB Cases with Padagis Us as petitioner: | See PTAB cases with Padagis Us as petitioner |
Drugs and US Patents for Padagis Us
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Padagis Us | TRIAMCINOLONE ACETONIDE | triamcinolone acetonide | OINTMENT;TOPICAL | 087385-002 | Approved Prior to Jan 1, 1982 | AT | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Padagis Us | GLYCOPYRRONIUM TOSYLATE | glycopyrronium tosylate | CLOTH;TOPICAL | 214448-001 | Apr 3, 2026 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Padagis Us | CENTANY | mupirocin | OINTMENT;TOPICAL | 050788-001 | Dec 4, 2002 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Padagis Us | BACITRACIN | bacitracin | OINTMENT;OPHTHALMIC | 061212-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Padagis Us | GENTAMICIN SULFATE | gentamicin sulfate | SOLUTION/DROPS;OPHTHALMIC | 065121-001 | Jan 30, 2004 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Padagis Us
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Padagis Us | BUTOCONAZOLE NITRATE | butoconazole nitrate | CREAM;VAGINAL | 019881-001 | Feb 7, 1997 | 5,993,856 | ⤷ Start Trial |
| Padagis Us | CLINDESSE | clindamycin phosphate | CREAM;VAGINAL | 050793-001 | Nov 30, 2004 | 5,993,856 | ⤷ Start Trial |
| Padagis Us | CLINDESSE | clindamycin phosphate | CREAM;VAGINAL | 050793-001 | Nov 30, 2004 | 6,899,890 | ⤷ Start Trial |
| Padagis Us | BUTOCONAZOLE NITRATE | butoconazole nitrate | CREAM;VAGINAL | 019881-001 | Feb 7, 1997 | 4,078,071 | ⤷ Start Trial |
| Padagis Us | CLINDESSE | clindamycin phosphate | CREAM;VAGINAL | 050793-001 | Nov 30, 2004 | 5,266,329 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for PADAGIS US drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Enteric Coated Capsules | 3 mg | ➤ Subscribe | 2008-02-01 |
| ➤ Subscribe | Vaginal Cream | 2% | ➤ Subscribe | 2015-02-05 |
International Patents for Padagis Us Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Brazil | PI0414500 | ⤷ Start Trial |
| Japan | 2009522361 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2005027807 | ⤷ Start Trial |
| Australia | 2006332519 | ⤷ Start Trial |
| Japan | 2007505927 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Padagis Us Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 3043773 | 132021000000191 | Italy | ⤷ Start Trial | PRODUCT NAME: MOMETASONE O UN SUO SALE E OLOPATADINA O UN SUO SALE(RYALTRIS); AUTHORISATION NUMBER(S) AND DATE(S): 048499014, 048499026, 048499038, 20210726;140638, 20210426 |
| 3043773 | 21C1057 | France | ⤷ Start Trial | PRODUCT NAME: MOMETASONE OU L'UN DE SES SELS AVEC OLOPATADINE OU L'UN DE SES SELS; NAT. REGISTRATION NO/DATE: NL52121 20211026; FIRST REGISTRATION: AT - 140638 20210426 |
| 0402407 | 97C0005 | Belgium | ⤷ Start Trial | PRODUCT NAME: ESTRADIOL HEMIHYDRAAT; NAT. REGISTRATION NO/DATE: 298 IS 190 F 15 19960806; FIRST REGISTRATION: GB PL/0053/0241 19950711 |
| 3043773 | SPC/GB21/077 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: MOMETASONE OR A SALT THEREOF AND OLOPATADINE OR A SALT THEREOF; REGISTERED: AT 140638 20210426; UK PL 25258/0331 - 0001 20210511 |
| 0247633 | 62/1997 | Austria | ⤷ Start Trial | PRODUCT NAME: ATORVASTATIN CALCIUM; NAT. REGISTRATION NO/DATE: 1-21926, 1-21927, 1-21928 19970411; FIRST REGISTRATION: GB PL 00018/0240 - PL 00018/0242 19961107 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
